Form 4: Exponent CEO exercises options, sells shares

Exponent CEO Catherine Corrigan exercised 5,605 options and sold 4,900 shares under a Rule 10b5-1 plan, boosting direct holdings to 84,134 shares.

Summary

• On 2025-11-17, President & CEO and Director Catherine Corrigan exercised 5,605 non-qualified stock options (3,225 at 25.405 and 2,380 at 29.05) and sold 4,900 shares (3,225 at 70.205 and 1,675 at 70.7387).
• Direct beneficial ownership increased by 705 shares to 84,134 following the transactions.
• Transactions were conducted pursuant to a Rule 10b5-1(c) trading plan.
• Per disclosure, the stock sales were to cover the option exercise price and associated taxes.
• Remaining unexercised options after the transactions include 19,353 at 25.405 (expiring 2026-07-29) and 19,038 at 29.05 (expiring 2027-02-16).

Sentiment

Score: 5

Explanation: Neutral administrative insider activity with a small net increase in CEO holdings; no operational or financial performance data.

Positives

• Net increase in direct ownership (+705 shares) to 84,134 shares.
• Use of a Rule 10b5-1 trading plan supports pre-arranged, compliant execution.
• Sales characterized as sell-to-cover for option exercise price and taxes, limiting discretionary selling.

Negatives

• Insider sales totaled 4,900 shares at prices around 70.21–70.74, which some investors may view cautiously.
• Upcoming option expirations in 2026 and 2027 could lead to additional exercises and associated sell-to-cover transactions.

Future Outlook

No operational or financial guidance is provided; the disclosure is limited to insider equity transactions executed under a Rule 10b5-1 plan.

Management Comments

• Sales were to cover the option exercise price and taxes.
• Transactions were executed under a Rule 10b5-1(c) trading plan.

Industry Context

Executive option exercises with concurrent sell-to-cover transactions under Rule 10b5-1 plans are routine across professional services and broader public company markets, and typically reflect administrative equity management rather than a directional view on fundamentals.

Comparison to Industry Standards

• Aligned with peers such as FTI Consulting (FCN), Huron Consulting (HURN), and CRA International (CRAI), where executives commonly use Rule 10b5-1 plans and sell shares to cover exercise costs and taxes.
• Resulting net increase in holdings is consistent with standard executive equity accumulation patterns following option exercises.
• Transaction structure (exercise plus sell-to-cover) mirrors common governance and compliance practices for insider trading at U.S.-listed companies.

Stakeholder Impact

• Issuance of 5,605 shares via option exercise marginally increases the share count.
• CEO directly holds 84,134 shares after the transactions.
• Sales designated as sell-to-cover reduce the likelihood of discretionary open-market selling pressure.

Next Steps

• Option grant expiring on 2026-07-29 may be exercised prior to expiration.
• Option grant expiring on 2027-02-16 may be exercised prior to expiration.

Key Dates

Keywords

Exponent, EXPO, Form 4, insider transaction, Catherine Corrigan, CEO, 10b5-1 trading plan, stock option exercise, sell to cover, professional services